CannBioRx Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . CannBioRx Life Sciences
ATNFW Stock  USD 0.01  0.0006  6.25%   
CannBioRx Life financial statements provide useful quarterly and yearly information to potential CannBioRx Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CannBioRx Life financial statements helps investors assess CannBioRx Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CannBioRx Life's valuation are summarized below:
Market Capitalization
250.8 M
There are over one hundred nineteen available fundamental signals for CannBioRx Life Sciences, which can be analyzed over time and compared to other ratios. All traders should should validate CannBioRx Life's prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable.
Check CannBioRx Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CannBioRx Life's main balance sheet or income statement drivers, such as Interest Expense of 48.98, Selling General Administrative of 7.6 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. CannBioRx financial statements analysis is a perfect complement when working with CannBioRx Life Valuation or Volatility modules.
  
Check out the analysis of CannBioRx Life Correlation against competitors.

CannBioRx Life Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.5 M4.7 M27.6 M
Pretty Stable
Total Current Liabilities8.6 M5.8 M4.9 M
Slightly volatile
Cash And Short Term Investments1.7 M1.8 M16.2 M
Very volatile
Capital Surpluse3.5 M4.5 M2.3 M
Slightly volatile
Total Liabilities11.6 M6.2 M6.5 M
Slightly volatile
Total Current Assets4 M4.2 M2.4 M
Slightly volatile
Short Term Debt1.5 M930.7 K1.4 M
Slightly volatile
Common Stock46.1748.613.5 M
Very volatile
Other Current Liabilities2.3 M2.5 M2.5 M
Slightly volatile
Cash3.2 M2.3 M1.8 M
Slightly volatile
Non Current Assets Total1.4 M1.5 M76.3 M
Slightly volatile
Common Stock Shares Outstanding414.2 K436 K1.7 M
Pretty Stable
Short Term Investments10.2 M10.7 M70.7 M
Slightly volatile
Liabilities And Stockholders Equity4.5 M4.7 M78.7 M
Slightly volatile
Non Current Liabilities Total277.5 K292.1 K3.2 M
Slightly volatile
Short and Long Term Debt Total1.9 M948.7 K2.9 M
Slightly volatile
Accounts Payable2.7 M1.7 M3.6 M
Slightly volatile
Net Receivables433.2 K251.1 K396.7 K
Slightly volatile
Common Stock Total Equity277.7 K312.4 K340.6 K
Slightly volatile
Other Current Assets1.6 M1.9 M683.3 K
Slightly volatile
Net Invested Capital792 K833.7 K32 M
Slightly volatile
Short and Long Term Debt1.8 M930.7 K2.9 M
Slightly volatile
Capital Stock46.1748.61.3 K
Slightly volatile
Intangible Assets1.4 M1.5 M11.9 M
Slightly volatile
Long Term Debt17 K17.9 K86.6 K
Slightly volatile

CannBioRx Life Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative7.6 M12.3 M4.7 M
Slightly volatile
Other Operating Expenses18.7 M15.5 M9.7 M
Slightly volatile
Total Operating Expenses18.7 M15.5 M9.7 M
Slightly volatile
Depreciation And Amortization101.1 K121.5 K59.9 K
Slightly volatile
Research Development2.7 M3.2 M1.8 M
Slightly volatile
Selling And Marketing Expenses12.9 T12.2 T2.9 T
Slightly volatile
Cost Of Revenue110.9 K121.5 K87.6 K
Slightly volatile
Reconciled Depreciation118.2 K138.7 K90.3 K
Slightly volatile

CannBioRx Life Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow1.9 M2.3 M1.2 M
Slightly volatile
Begin Period Cash Flow8.4 M8 M2.1 M
Slightly volatile
Depreciation98.6 K121.5 K47.4 K
Slightly volatile
Stock Based Compensation3.3 M2.1 M9.1 M
Slightly volatile
Issuance Of Capital Stock13 M21.3 M6.5 M
Slightly volatile
Dividends Paid379.8 K427.3 K465.9 K
Slightly volatile
Change To Account Receivables44.8 K50.4 K55 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Average Payables3.4 M2.1 M5 M
Slightly volatile
Capex To Depreciation0.00.00.8763
Slightly volatile
Payables Turnover0.05550.05030.0382
Slightly volatile
Cash Per Share5.76.06.6 K
Slightly volatile
Days Payables Outstanding13.2 K7.5 K16.7 K
Slightly volatile
Intangibles To Total Assets0.70.350.4454
Slightly volatile
Current Ratio0.870.831.4388
Slightly volatile
Graham Number21.8222.971.1 K
Pretty Stable
Capex Per Share0.00.02.0452
Slightly volatile
Interest Debt Per Share3.043.289.5573
Slightly volatile
Debt To Assets0.190.180.0886
Slightly volatile
Days Of Payables Outstanding13.2 K7.5 K16.7 K
Slightly volatile
Total Debt To Capitalization1.081.020.2713
Slightly volatile
Quick Ratio0.850.831.4321
Slightly volatile
Net Income Per E B T0.710.810.662
Slightly volatile
Cash Ratio0.670.451.2372
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.820.941.003
Slightly volatile
Debt Ratio0.190.180.0886
Slightly volatile

CannBioRx Life Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.7 M1.8 M34 M
Slightly volatile
Enterprise Value674.1 K709.6 K34.9 M
Slightly volatile

CannBioRx Fundamental Market Drivers

Cash And Short Term Investments2 M

About CannBioRx Life Financial Statements

CannBioRx Life investors use historical fundamental indicators, such as CannBioRx Life's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CannBioRx Life. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-1.7 T-1.6 T
Cost Of Revenue121.5 K110.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
BTCBitcoin
TRXTRON
BNBBinance Coin

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY